March 18, 2024 by Chain Drug Review
Circana, Growth Leaders
Leading Headlines
CHICAGO – Circana, a leading advisor on the complexity of consumer behavior, on Monday issued its annual Growth Leaders rankings. The firm analyzed the growth performance of hundreds of public and private consumer packaged goods (CPG) companies ranging from $100 million to $60 billion in annual sales to develop the rankings. Circana will highlight the
March 18, 2024 by Chain Drug Review
Camber
Pharmacy, Supplier News
PiISCATAWAY, N.J. — Camber Pharmaceuticals has added gabapentin tablets (generic for Gralise) to its portfolio. Camber already offers gabapentin tablets and capsules (generic for Neurontin). Generics for Gralise and Neurontin are not interchangeable. Gabapentin tablets (generic for Gralise) are indicated for the management of postherpetic neuralgia (PHN). Gabapentin tablets (generic for Gralise) 300 mg and
March 18, 2024 by Chain Drug Review
AllianceRx Walgreens, Vivjoa
Leading Headlines
DEERFIELD, Ill. — Specialty pharmacy patients now have exclusive access to VIVJOA through AllianceRx Walgreens Pharmacy. VIVJOA (oteseconazole), manufactured by Mycovia Pharmaceuticals, Inc., is the first FDA-approved medication to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in post-menopausal women or women who are not of reproductive potential. The addition of this medication brings Walgreens enterprise specialty’s number of exclusive
March 18, 2024 by Chain Drug Review
NRF, Retail employment
Featured Articles, Leading Headlines
WASHINGTON – The retail industry continues to be a top employer, according to a new report released by the National Retail Federation on Monday, which found that retailers supported 55 million full-time and part-time jobs in 2022, accounting for 26% of total U.S. employment. The figures are up from 52 million jobs and 25% of
March 14, 2024 by Chain Drug Review
CRN files lawsuit challenging unconstitutional law that restricts access to health products
Leading Headlines, Supplier News
WASHINGTON — The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, today announced the filing of a lawsuit challenging the constitutionality of a recently enacted New York law that would restrict consumer access to safe and beneficial health products. The suit seeks an injunction to prohibit
March 7, 2024 by Chain Drug Review
Bast, Greater Than One
Supplier News
NEW YORK — Andrew Bast will be rejoining Media marketing and technology agency Greater Than One as chief strategy officer. Bast brings the art and science of strategic planning to forge dynamic, insight-driven strategies which resonate deeply with clients’ customers, the agency says. He has launched and grown many brands, including Nexium, Rexulti, Seroquel, Enbrel,
February 28, 2024 by Chain Drug Review
Eckerd, Stew Turley
Leading Headlines, Retail News
TAMPA — Stew Turley, who guided the evolution of Eckerd Corp. for three decades, died last week at his home in Florida after a battle with lymphoma. He was 89. During the course of his tenure at the retailer, which began in 1966 when he was named manager of non-drug operations, Eckerd grew to 2,778
February 21, 2024 by Chain Drug Review
Greater Than One, Valdez
Supplier News
NEW YORK — Jason Valdez has been promoted to chief operating officer of Greater Than One, a media marketing and technology agency focused on healthcare. He is responsible for overall operations and ensuring the agency’s mission of building better healthcare experiences for customers. He will work directly with CEO Elizabeth Apelles to align the agency
February 21, 2024 by Chain Drug Review
Loblaw to invest more than $2 billion in the Canadian economy, opening more than 40 additional stores
Leading Headlines, Retail News
BRAMPTON, ON – Loblaw Cos., Canada’s food and pharmacy retail leader, expects to invest more than $2 billion dollars into the Canadian economy in 2024. This record investment reflects Loblaw’s commitment to enhancing its store network, creating job opportunities, and improving accessibility to affordable food and healthcare services for communities across the country. The Company’s capital investments this
February 21, 2024 by Chain Drug Review
Cepham introduces Senolytics inspired by Ayurveda and TCM for sustainable aging
Supplier News
SOMERSET, N.J. — Cepham, a leader in Ayurvedic nutraceuticals research and sustainable self-care solutions, has announced the expansion of its Sustainable Aging product line to include senolytics, aimed at redefining approaches to healthy aging. Senescent cells are colloquially known as “zombie cells” among scientists, due to their lingering presence in the body, which can lead
February 7, 2024 by Chain Drug Review
CVS, fourth quarter
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health topped analysts’ forecasts for fourth quarter sales and profits, but cut its full year earnings outlook, citing rising medical costs that are hurting the insurance industry. Revenue for the three months ended December 31 climbed 11.9% from the year-ago period to $93.81 billion, beating Wall Street’s estimate of $90.41 billion.
January 31, 2024 by Chain Drug Review
Discount Drug Mart, vehicle registration
Leading Headlines, Retail News
LAKEWOOD, Ohio — Discount Drug Mart, the regional chain that “Saves you the Run Around,” is now saving time on vehicle registration renewals. A new self-service Ohio Bureau of Motor Vehicles Express Kiosk opened at the Medina, Ohio-based retailer’s store at 15412 Detroit Road in Lakewood, letting drivers renew their registration and receive their validation
January 4, 2024 by Chain Drug Review
first quarter, Pessina, WBA, Wentworth
Featured Articles, Leading Headlines
DEERFIELD, Ill. — Walgreens Boots Alliance topped Wall Street’s expectations for first quarter sales and earnings, but slashed its quarterly dividend nearly in half. WBA cut its dividend to 25 cents per share from 48 cents per share, reducing the payout for the first time in nearly five decades. New CEO Tim Wentworth, who took
December 11, 2023 by Chain Drug Review
NACDS praises House passage of bipartisan bill to help deliver essential PBM reforms in Medicaid
Leading Headlines, Pharmacy
WASHINGTON — NACDS is applauding the passage of the Lower Costs, More Transparency Act (H.R. 5378) by the U.S. House of Representatives today. The bill — which was introduced by U.S. Representative Cathy McMorris Rodgers (R-WA) on September 8 — is a vital aspect of pharmacy benefit manager (PBM) reform. Among its provisions, it addresses the “pharmaceutical